Many life sciences compliance teams believe their spend transparency processes are “good enough” until an auditor, a regulator, or a journalist starts asking pointed questions about specific payments to specific physicians. At that moment, “good enough” isn’t a defense. It’s a liability.
Aggregate spend transparency obligations — Sunshine Act/Open Payments in the U.S., EFPIA disclosure codes in Europe, and a growing patchwork of country-specific requirements around the world — aren’t going away, and enforcement scrutiny is only increasing. CMS’s own reporting to Congress shows a steady climb in pre-demand letters and civil monetary penalties for Sunshine Act noncompliance in recent years, and the agency has said explicitly that any reporting entity can be selected for audit — through a mix of risk-based targeting (data irregularities, inconsistent patterns, credible tips, prior noncompliance) and random selection. In other words, filing on time is no longer enough. Regulators want to see a defensible, auditable trail behind every dollar, every transfer of value, and every stakeholder relationship.
The problem is that most breakdowns in spend transparency don’t announce themselves. They hide in spreadsheets, disconnected systems, and “we’ve always done it this way” workflows, until an audit shines a light on them. Here are five warning signs that your current process is more fragile than your team may even realize.
-
Your data lives in multiple systems that don’t talk to each other
CMS’s Open Payments program now reflects data from well over 1,800 manufacturers and GPOs covering payments to more than 1,000,000 physicians, non-physician practitioners, and teaching hospitals — and that’s just the U.S. federal layer, before state-specific laws and international disclosure requirements are layered on top. At that scale, if your spend data is scattered across CRM exports, T&E platforms, procurement tools, and manually maintained spreadsheets, you already have an audit problem. Every handoff between systems is a place where data gets duplicated, dropped, or misclassified — and every gap is a question an auditor can ask that you may not be able to immediately answer.
A defensible process starts with a single source of truth: one platform that ingests spend data from any source system, normalizes it, and gives your team a consolidated view before a report ever gets generated. If your team can’t produce a complete, reconciled picture of global spend in minutes rather than days, your process is running on borrowed time.
-
Data validation happens after the report is already built
Many compliance teams treat data validation as a final “sanity check” — something that happens after data is compiled into a submittable report, rather than as a built-in step throughout the process. This is backwards. It means errors are caught late (or not at all), remediation becomes a scramble against filing deadlines, and there’s no clear record of what was flagged, fixed, or accepted.
An audit-ready process validates data as it comes in — flagging incomplete records, duplicate transactions, and misclassified transfers of value early, with a documented workflow showing exactly how each issue was identified and resolved. If your validation process can’t produce that paper trail, you don’t have a compliance process — you have a hope.
-
Fair Market Value rates aren’t consistent — or documented — across the organization
Because many reportable payments are tied directly to Fair Market Value (FMV), inconsistent FMV methodology is one of the fastest ways to turn a routine audit into a serious finding. If different brands, regions, or business units are tiering KOLs and calculating FMV rates using different logic, spreadsheets, or “tribal knowledge,” you have no consistent, defensible standard to point to when a regulator asks how a specific rate was determined.
A mature process uses standardized, auditable workflows for KOL tiering and FMV rate calculation — including a clear, documented exception process for any rate that falls outside the norm. If you can’t quickly answer “why was this HCP paid this rate,” your FMV governance has a gap.
-
Your third-party and stakeholder due diligence isn’t connected to your spend data
Spend transparency doesn’t exist in isolation. Every transfer of value involves a stakeholder and if your due diligence on those third parties lives in a separate process (or doesn’t exist at all), you’re reporting spend without full visibility into who you’re actually paying and why.
Auditors increasingly look at spend transparency and third-party risk together. Can you demonstrate that the stakeholders receiving payments were properly screened, that engagements were tied to legitimate business purposes, and that the full lifecycle — from engagement planning to payment to reporting — is connected? If those pieces live in disconnected silos, your transparency data is only as strong as its weakest, least-visible link.
It’s worth distinguishing scope here. A Sunshine Act audit — verification of transfers of value reported under CMS’s Open Payments program — is a narrow, purpose-built exercise. It confirms that payments to covered recipients (physicians, teaching hospitals, and other practitioner types now captured under CMS’s expanded definitions) were captured accurately, categorized correctly, and reported within the required thresholds and timeframes. By design, it does not reach into third-party payments that fall outside Open Payments’ reporting criteria: non-covered recipients, sub-threshold payments, or engagements with vendors and consultants who aren’t healthcare providers at all.
That narrowness is exactly why the broader lifecycle connection matters. The screening, business-purpose justification, and engagement-to-payment traceability that make a Sunshine audit defensible are the same controls a general third-party risk program needs for the payments Sunshine reporting never touches — anti-kickback exposure, third-party due diligence relevant to FCPA and similar regimes, and conflict-of-interest management. A clean Sunshine audit confirms your reportable HCP payments are in order. It says nothing about whether the rest of your third-party spend was screened, justified, or traceable. Organizations that treat Sunshine compliance and third-party risk management as one system, rather than connected but distinct ones, often find the gap only when a non-reportable engagement becomes a regulatory or reputational problem.
-
Your team can’t answer “why” — only “what”
The most telling audit warning sign isn’t a wrong number. It’s a compliance team that can produce the report but can’t explain the story behind it: why a payment was classified the way it was, why a threshold was or wasn’t triggered, why a jurisdiction’s rules were applied a certain way. CMS itself has stated that reporting entities should keep assumptions documents, supporting books and records for five years from the date data is published — meaning your team needs to be able to answer “why,” not just for this reporting cycle, but for years’ worth of past submissions. Regulators globally are moving faster than ever — new jurisdictions, changing thresholds, evolving disclosure codes — and a process that isn’t built to track and apply those changes in real time will eventually fall out of step with what’s actually required.
If your team is relying on institutional memory, outdated PDFs, or a scramble to research “what changed this year” every reporting cycle, you’re one regulatory update away from a preventable finding.
What an audit-ready spend transparency process actually looks like
None of these warning signs are inevitable. They’re symptoms of processes that were built to meet a deadline rather than withstand scrutiny. An audit-ready approach to commercial compliance connects the full picture:
- A single platform to import, validate, report, and analyze aggregate spend data — instead of stitching together spreadsheets and disconnected systems
- Built-in validation workflows that catch and document data issues before they become findings
- Standardized, auditable FMV and stakeholder engagement workflows so every rate and every relationship can be explained, not just reported
- Real-time regulatory intelligence so your team always knows what’s changed and where, across every jurisdiction you operate in
- Connected third-party due diligence so spend data and stakeholder risk aren’t managed in silos
This is exactly the gap Medispend’s Commercial Compliance solutions are built to close. Our Spend Transparency solution gives life sciences companies of every size an end-to-end, audit-ready process for global aggregate spend reporting, whether through Reporting-as-a-Service, our full SaaS Transparency Solution, or Managed Services. Paired with FMV Data Management, Third-Party Due Diligence, and the Global Compliance Digest’s real-time access to over 70,000 regulatory data points, it’s a complete foundation for growing your business compliantly.
Not sure how your current process would hold up? Contact us to schedule a discovery call to see where your spend transparency process stands and what it would take to make it audit-ready.
Jay Ward
Life Sciences Solutions Director
